Step 1 of 2
Patients’ triglyceride levels will determine your clinical priority in managing severe hypertriglyceridemia (sHTG), whether it is atherosclerotic cardiovascular disease (ASCVD) or acute pancreatitis risk reduction. Access these slides to learn best practices in recognizing and diagnosing patients with sHTG, assessing their ASCVD and acute pancreatitis risk, initiating foundational therapy, and escalating to ApoC-III–targeted agents through coordinated, multidisciplinary care.